Jacobio Pharmaceuticals Group Co., Ltd. Stock
Equities
1167
KYG4987A1094
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.87 HKD | +1.08% | +0.54% | -48.34% |
Sales 2024 * | - | Sales 2025 * | 60.31M 8.35M 65.1M | Capitalization | 1.36B 188M 1.46B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 462M 63.99M 499M | Net cash position 2025 * | 703M 97.25M 759M | EV / Sales 2025 * | 10.8 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 301 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.92% |
1 day | +1.08% | ||
1 week | +0.54% | ||
Current month | +10.65% | ||
1 month | +24.67% | ||
3 months | -24.60% | ||
6 months | -55.48% | ||
Current year | -48.34% |
Managers | Title | Age | Since |
---|---|---|---|
Yin Xin Wang
CEO | Chief Executive Officer | 59 | 18-05-31 |
Hai Jun Wang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 54 | 20-07-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rui Lin Song
BRD | Director/Board Member | 61 | 20-08-19 |
Xiaojie Wang
ADM | Chief Administrative Officer | 60 | 18-07-30 |
Yun Yan Hu
BRD | Director/Board Member | 61 | 18-07-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.85% | 4 M€ | -27.92% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 1.87 | +1.08% | 527 100 |
24-05-16 | 1.85 | +1.65% | 972,600 |
24-05-14 | 1.82 | +1.11% | 1,405,500 |
24-05-13 | 1.8 | -3.23% | 2,473,800 |
24-05-10 | 1.86 | -7.46% | 2,889,900 |
Delayed Quote Hong Kong S.E., May 16, 2024 at 11:58 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-48.34% | 188M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- 1167 Stock